G24:XETRScout24 SE Analysis
Data as of 2026-08-26 - not real-time
€79.65
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Scout24 SE trades at €79.65, with its moving averages tangled rather than clearly stacked — a neutral trend structure. It has gained 6.6% over the past 30 days. With RSI at 59.3 the momentum picture is neutral, alongside a bullish MACD signal. Price has been bracketed by support at €69.50 and resistance at €81.70.
Multiples put this in fair territory: 20.1 times earnings against the sector's 16.4. The average analyst target implies 33.0% above today's level. Revenue is growing at 20.0% on a 40.2% profit margin. The 1.94% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 43.7%, a beta of -0.11 and a maximum drawdown of 45.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to buy, carrying 5/10 conviction.
Multiples put this in fair territory: 20.1 times earnings against the sector's 16.4. The average analyst target implies 33.0% above today's level. Revenue is growing at 20.0% on a 40.2% profit margin. The 1.94% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 43.7%, a beta of -0.11 and a maximum drawdown of 45.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to buy, carrying 5/10 conviction.
Top Market Events
Yahoo Finance3monScout24 SE N G24.DE Q1 FY2026 earnings call transcriptScout24 delivered a strong Q1 2026, with revenue...Yahoo Finance3monScout24 SE N G24.F Q1 FY2026 earnings call transcriptScout24 delivered a strong Q1 2026, with revenue...Yahoo Finance3monSCOUT24 SE G24.VI Q1 FY2026 earnings call transcriptScout24 delivered a strong Q1 2026, with revenue...
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 5/10
Key Factors
- Trading above the 200-day average of 76.02
- MACD momentum is positive
- 30-day price change of +6.6%
Medium Term
1–3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 20.1 versus sector average of 16.4
- Trading above the 200-day average of 76.02
- Analyst targets imply +33.0% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 20.1 versus sector average of 16.4
- Analyst targets imply +33.0% versus the current price
- Profit margin of 40.2% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth20.00%
Profit Margin40.18%
P/E Ratio20.1
ROE22.82%
ROA10.10%
Debt/Equity59.48
P/B Ratio4.8
Op. Cash Flow€272.0M
Free Cash Flow€262.3M
Industry P/E16.4
Technical Analysis
TrendNeutral
RSI59.3
Support€69.50
Resistance€81.70
MA 20€76.46
MA 50€74.41
MA 200€76.02
MACDBullish
VolumeDecreasing
Fear & Greed Index93.39
Valuation
Fair Value€99.50
Target Price€105.91
Upside/Downside32.96%
GradeFair
TypeGrowth
Dividend Yield1.94%
Risk Assessment
Beta-0.11
Volatility43.67%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.